- Home
- ONTO vs ARWR Comparison
ONTO vs ARWR Comparison
Compare ONTO & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONTO | ARWR |
|---|---|---|
| Founded | 1940 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.0B |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ONTO | ARWR |
|---|---|---|
| Price | $189.68 | $57.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $229.38 | $81.50 |
| AVG Volume (30 Days) | 652.0K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ 2.78 | 0.22 |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $26.63 | N/A |
| Revenue Next Year | $16.26 | N/A |
| P/E Ratio | ★ $73.28 | $262.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $89.40 | $10.66 |
| 52 Week High | $232.49 | $76.76 |
Technical Indicators
Market Signals| Indicator | ONTO | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 43.26 |
| Support Level | $178.40 | $54.02 |
| Resistance Level | $229.81 | $66.37 |
| Average True Range (ATR) | 10.60 | 2.99 |
| MACD | -0.09 | 0.31 |
| Stochastic Oscillator | 17.74 | 37.68 |
Price Performance
Historical ComparisonAbout ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.